New research on T1D! Key biomarkers like lipase & trypsinogen help differentiate clinical groups, with their utility shaped by genetic risk & autoantibody status. Exciting potential for early diagnosis & monitoring! T1D DiabetesResearch (by our members at University of Florida) lnkd.in/etm2CgZu
Lipase and trypsinogen biomarkers differentiate type 1 diabetes groups
More from GCDTR
All news
Dr. Jacob Kariuki receives NIH R01 for PATH activity program
Congratulations to Dr. Jacob Kariuki (Kigo Kariuki), Associate Professor at Nell Hodgson Woodruff School of Nursing at Emory University on receiving an NIH R01 award to advance his research on Physical Activity for The Heart (PATH)!
Congratulations to GCDTR, Director and Emory Global Diabetes Research Center, Director of Data Analytics & Reporting, Dr....
Congratulations to GCDTR, Director and Emory Global Diabetes Research Center, Director of Data Analytics & Reporting, Dr. Jeff Mills, Ed.D, MBA on receiving an National Science Foundation (NSF)-supported ACCESS Discovery Project! ACCESS is a National Science Foundation-supported program that connects…
Roy Beck identifies donor damage and complications increase DMEK cell loss
What factors influence corneal graft health after Descemet membrane endothelial keratoplasty (DMEK)?